(Q52531516)

2 May 2018

review article

1 reference

title

AmBisome (liposomal amphotericin B): a comparative review. (English)

1 reference

2 May 2018

1 reference

Boswell GW

1

1 reference

2 May 2018

Buell D

series ordinal

2

1 reference

2 May 2018

Bekersky I

series ordinal

3

1 reference

2 May 2018

publication date

1 July 1998

1 reference

2 May 2018

The Journal of Clinical Pharmacology

published in

1 reference

2 May 2018

volume

38

1 reference

2 May 2018

page(s)

583-592

1 reference

2 May 2018

issue

7

1 reference

2 May 2018

Lipid formulations of amphotericin B: recent progress and future directions

cites work

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04464.X

Unusual lipid structures selectively reduce the toxicity of amphotericin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04464.X

Comparative pharmacokinetics of amphotericin B after administration of a novel colloidal delivery system, ABCD, and a conventional formulation to rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04464.X

Pharmacokinetics and safety of a unilamellar liposomal formulation of amphotericin B (AmBisome) in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04464.X

Relationship of pharmacokinetics and drug distribution in tissue to increased safety of amphotericin B colloidal dispersion in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04464.X

Tissue Distribution of Amphotericin B Lipid Complex in Laboratory Animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04464.X

10.1002/J.1552-4604.1998.TB04464.X

21 January 2018

Identifiers

DOI

1 reference

2 May 2018

PubMed ID

9702842

1 reference

2 May 2018